이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Jacobson Pharma 관리
관리 기준 확인 1/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Derek Sum
최고 경영자
HK$20.8m
총 보상
| CEO 급여 비율 | 19.6% |
| CEO 임기 | 8.7yrs |
| CEO 소유권 | 60.2% |
| 경영진 평균 재임 기간 | 데이터 없음 |
| 이사회 평균 재임 기간 | 8.5yrs |
최근 관리 업데이트
Increases to Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Might Cool off for now
Aug 21
Should Shareholders Reconsider Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Package?
Sep 16Recent updates
Increases to Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Might Cool off for now
Aug 21Jacobson Pharma's (HKG:2633) Profits May Not Reveal Underlying Issues
Dec 21Jacobson Pharma's (HKG:2633) Dividend Is Being Reduced To HK$0.025
Nov 27These 4 Measures Indicate That Jacobson Pharma (HKG:2633) Is Using Debt Reasonably Well
Jun 20Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's
Nov 28Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.0268
Sep 25Should Shareholders Reconsider Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Package?
Sep 16Jacobson Pharma's (HKG:2633) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 28Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's
Jul 14Does Jacobson Pharma (HKG:2633) Have A Healthy Balance Sheet?
Feb 09Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.012
Nov 29Jacobson Pharma (HKG:2633) Is Reducing Its Dividend To HK$0.015
Sep 24Here's Why It's Unlikely That Jacobson Pharma Corporation Limited's (HKG:2633) CEO Will See A Pay Rise This Year
Sep 16Kwing Tong Lam Is The Independent Non-Executive Director of Jacobson Pharma Corporation Limited (HKG:2633) And They Just Picked Up 28% More Shares
Feb 03
A Look At The Fair Value Of Jacobson Pharma Corporation Limited (HKG:2633)
Jan 24Here's Why Jacobson Pharma (HKG:2633) Has A Meaningful Debt Burden
Jan 11Does Jacobson Pharma's (HKG:2633) CEO Salary Compare Well With The Performance Of The Company?
Dec 27Is It Smart To Buy Jacobson Pharma Corporation Limited (HKG:2633) Before It Goes Ex-Dividend?
Dec 12Reflecting on Jacobson Pharma's (HKG:2633) Share Price Returns Over The Last Three Years
Dec 03CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Mar 31 2024 | HK$21m | HK$4m | HK$186m |
| Dec 31 2023 | n/a | n/a | HK$221m |
| Sep 30 2023 | n/a | n/a | HK$217m |
| Jun 30 2023 | n/a | n/a | HK$234m |
| Mar 31 2023 | HK$14m | HK$3m | HK$175m |
| Dec 31 2022 | n/a | n/a | HK$207m |
| Sep 30 2022 | n/a | n/a | HK$203m |
| Jun 30 2022 | n/a | n/a | HK$190m |
| Mar 31 2022 | HK$5m | HK$3m | HK$178m |
| Dec 31 2021 | n/a | n/a | HK$166m |
| Sep 30 2021 | n/a | n/a | HK$154m |
| Jun 30 2021 | n/a | n/a | HK$164m |
| Mar 31 2021 | HK$5m | HK$4m | HK$174m |
| Dec 31 2020 | n/a | n/a | HK$183m |
| Sep 30 2020 | n/a | n/a | HK$191m |
| Jun 30 2020 | n/a | n/a | HK$203m |
| Mar 31 2020 | HK$5m | HK$4m | HK$214m |
| Sep 30 2019 | n/a | n/a | HK$273m |
| Jun 30 2019 | n/a | n/a | HK$259m |
| Mar 31 2019 | HK$5m | HK$4m | HK$245m |
| Dec 31 2018 | n/a | n/a | HK$235m |
| Sep 30 2018 | n/a | n/a | HK$219m |
| Jun 30 2018 | n/a | n/a | HK$211m |
| Mar 31 2018 | HK$6m | HK$4m | HK$202m |
보상 대 시장: Derek 의 총 보상 ($USD 1.75M )은 Hong Kong 시장( $USD 351.75K ).
보상과 수익: Derek 의 보상은 지난 1년 동안 20% 이상 증가했습니다.
CEO
Derek Sum (61 yo)
8.7yrs
테뉴어
HK$20,779,000
보상
Mr. Kwong Yip Sum, also known as Derek, is Non-Executive Chairman of the Board at JBM (Healthcare) Limited since September 22, 2020. He joined the company and its subsidiaries September 22, 2020. With exte...
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chairman | 8.7yrs | HK$20.78m | 60.18% HK$ 762.6m | |
| VP of Administration & Executive Director | 7.7yrs | HK$3.18m | 0.42% HK$ 5.3m | |
| Executive Director | 8.5yrs | HK$6.77m | 2.04% HK$ 25.9m | |
| Independent Non-Executive Director | 8.5yrs | HK$230.00k | 데이터 없음 | |
| Independent Non-Executive Director | 8.2yrs | HK$230.00k | 데이터 없음 | |
| Member of Scientific Advisory Committee | 8.5yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Committee | 8.5yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Committee | 8.5yrs | 데이터 없음 | 데이터 없음 | |
| Non-Executive Director & Member of Scientific Advisory Committee | 8.5yrs | HK$230.00k | 데이터 없음 | |
| Independent Non-Executive Director | 8.2yrs | HK$230.00k | 0.030% HK$ 384.0k |
8.5yrs
평균 재임 기간
61yo
평균 연령
경험이 풍부한 이사회: 2633 의 이사회는 경험(평균 재직 기간 8.2 년)으로 간주됩니다.